Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

MREO holding history

Mereo BioPharma Group plc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MREO overviewAll 13F holders of MREOFull Q2 2026 holdings

Shares (Q2 2026)
1,447,627
Value
$460.3K
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of MREO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,447,627$460.3K<0.1%−42,501−2.9%ReducedHolders
Q1 20261,490,128$491.7K<0.1%−68,803−4.4%ReducedHolders
Q4 20251,558,931$650.1K<0.1%+588,264+60.6%AddedHolders
Q3 2025970,667$2.00M<0.1%+597,162+159.9%AddedHolders
Q2 2025373,505$1.01M<0.1%−558,516−59.9%ReducedHolders
Q1 2025932,021$2.10M<0.1%−1,716,119−64.8%ReducedHolders
Q4 20242,648,140$9.27M<0.1%+2,648,140NewHolders
Q1 20240$00.0%−2,813−100.0%Sold outHolders
Q4 20232,813$6.50K<0.1%+2,813NewHolders
Q3 20230$00.0%−2,491−100.0%Sold outHolders
Q2 20232,491$3.29K<0.1%−93,666−97.4%ReducedHolders
Q1 202396,157$68.0K<0.1%−32,384−25.2%ReducedHolders
Q4 2022128,541$96.4K<0.1%−38,964−23.3%ReducedHolders
Q3 2022167,505$144.0K<0.1%+127,505+318.8%AddedHolders
Q2 202240,000$45.0K<0.1%+40,000NewHolders
Q1 20220$00.0%−23,306−100.0%Sold outHolders
Q4 202123,306$37.0K<0.1%+13,357+134.3%AddedHolders
Q3 20219,949$24.0K<0.1%+9,019+969.8%AddedHolders
Q2 2021930$3.00K<0.1%−4,189−81.8%ReducedHolders
Q1 20215,119$17.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.